432 related articles for article (PubMed ID: 7923985)
1. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
Floege J; Koch KM
Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
[No Abstract] [Full Text] [Related]
2. [Amyloidosis of the dialysis patient].
van Ypersele de Strihou C
Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
[No Abstract] [Full Text] [Related]
3. [Prevention of dialysis-related amyloidosis].
Yamamoto S; Gejyo F; Kazama JJ
Nihon Rinsho; 2004 Jun; 62 Suppl 6():353-6. PubMed ID: 15250323
[No Abstract] [Full Text] [Related]
4. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
Czyz W; Szepietowski T
Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
[TBL] [Abstract][Full Text] [Related]
5. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility study on cuprophane and polysulphone dialysers.
Taraba I; Polner K; Makó J
Nephrol Dial Transplant; 1991; 6 Suppl 3():22-5. PubMed ID: 1775261
[No Abstract] [Full Text] [Related]
7. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
[TBL] [Abstract][Full Text] [Related]
8. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
9. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
[TBL] [Abstract][Full Text] [Related]
10. Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes.
Campistol JM; Torregrosa JV; Ponz E; Fenollosa B
Contrib Nephrol; 1999; 125():76-85. PubMed ID: 9895432
[No Abstract] [Full Text] [Related]
11. Beta 2-microglobulin kinetics during haemofiltration.
Floege J; Wilks M; Shaldon S; Koch KM; Smeby LC
Nephrol Dial Transplant; 1988; 3(6):784-9. PubMed ID: 3147420
[TBL] [Abstract][Full Text] [Related]
12. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
Lee CJ; Hsiong CH; Chang YL; Cheng CH; Lian JD
ASAIO J; 1994; 40(1):62-6. PubMed ID: 8186494
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
Kopeć J
Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
Higuchi N; Maruyama H
Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
[TBL] [Abstract][Full Text] [Related]
15. [Beta 2-microglobulin kinetics during hemodialysis with different membranes].
Stetsiuk EA; Siniukhin VN; Danilkov AP; Shpazhnikova NS; Nikolaeva NP; Khamaganova EG
Urol Nefrol (Mosk); 1995; (3):18-20. PubMed ID: 7618215
[TBL] [Abstract][Full Text] [Related]
16. High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results.
David S; Cambi V
Contrib Nephrol; 1999; 125():96-110. PubMed ID: 9895434
[No Abstract] [Full Text] [Related]
17. Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis?
Risler T; Braun N; Hanel KD; Kuhlmann U; Skroch D; Müller GA
Int J Artif Organs; 1994 Nov; 17(11):581-4. PubMed ID: 7744517
[TBL] [Abstract][Full Text] [Related]
18. [Craniocervical amyloid tumor with destructive spondyloarthropathy and myelocompression as a rare complication of long-term dialysis].
Ausserwinkler M; Karlo O; Ebner F; Schmidt P
Wien Klin Wochenschr; 1990 Mar; 102(5):152-5. PubMed ID: 2108522
[TBL] [Abstract][Full Text] [Related]
19. beta 2-microglobulin and amyloidosis: who is at risk?
Davison AM
Nephrol Dial Transplant; 1995; 10 Suppl 10():48-51. PubMed ID: 8825433
[No Abstract] [Full Text] [Related]
20. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
Sulková S; Lapcík O; Votruba T
Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
